Net institutional outflow of $693 million and 284 sellers vs. 256 buyers confirm distribution. A mere $4,364 insider buy (25 shares) offers no support.

Confirmation

Continued net selling by institutions or an uptick in insider sales would reinforce the bearish case.

Invalidation Risk

A shift to institutional accumulation or a surge in insider buying would invalidate this verdict.

The above is AI-generated from public regulatory filings and summarizes historical data only. It is not investment advice and should not be used as the basis for any buy or sell decision.

Insider Trading (Form 4)

3290d confidence

unique buyers

$4K

buy value

data as of 2026-07-16

12-Month Buy/Sell Activity

Feb 25

Mar 26

BuySell

操作	內部人	職稱	交易日	金額
買入	LaPlume Joseph W	EVP, Corp Strategy & Develop	2026-03-03	$4K
賣出	LaPlume Joseph W	EVP, Corp Strategy & Develop	2025-08-22	$65K
賣出	LaPlume Joseph W	EVP, Corp Strategy & Develop	2025-08-18	$126K
賣出	LaPlume Joseph W	EVP, Corp Strategy & Develop	2025-08-07	$60K
賣出	MASSARO GEORGE	Director	2025-05-15	$5K
賣出	MASSARO GEORGE	Director	2025-05-15	$11K
賣出	MASSARO GEORGE	Director	2025-05-15	$3K
賣出	MASSARO GEORGE	Director	2025-05-14	$3K

View all insider trades →

Form 144 Pre-Sale Notices

Filings (90d)

$16.88M

Total Est. Value

75K shares

Planned Shares

Last Filed 2026-06-29

Filer	Title/Relationship	Filing Date	Planned Shares	Est. Value
FOSTER JAMES C	Director	2026-06-29	75K shares	$16.88M

Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker。

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding CHARLES RIVER LABORATORIES (CRL)?

Major stakeholders currently include BlackRock, Inc. ($665.7M), FMR LLC ($596.2M), Vanguard Capital Management LLC ($552.4M). Based on the latest 13F filings, there are a total of 558 tracked investment funds and institutions maintaining positions in CRL.

What is the overall institutional sentiment toward CRL recently?

Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $693.0M, driven by 256 managers accumulating shares while 284 reduced their exposure.

Which institutions have been selling or reducing their CRL positions?

In the latest period, 198 funds trimmed their holdings, and 86 managers completely exited their positions. The aggregate reported sell value was $3.7B.

Are there any notable investors adding CRL to their portfolios?

Yes, buying activity remains notable. 62 institutions opened new positions in {ticker}, and 194 existing holders added to their shares. The total reported buy value for the quarter amounted to $6.4B.